首页> 外文期刊>Journal of neurosurgery. Pediatrics. >Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery: Case report
【24h】

Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery: Case report

机译:新辅助化疗和手术成功治疗出血性先天性颅内未成熟畸胎瘤:病例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Congenital intracranial immature teratomas carry a dismal prognosis, and the usefulness of chemotherapy for these tumors has not been elucidated. The authors report on the successful management of a case of congenital intracranial immature teratoma by using neoadjuvant chemotherapy and surgery after the failure of an initial attempt at resection. The patient was an infant who had begun vomiting frequently at the age of 12 days and had been admitted to a hospital at the age of 18 days with continued vomiting, increased head circumference, and disturbance of consciousness. A CT scan of the brain revealed a large mass in his posterior fossa and hydrocephalus. Surgery was performed on an emergent basis, but only minor tumor resection could be performed due to massive intraoperative hemorrhage. The histopathological diagnosis was immature teratoma. Postoperatively, the infant was in critical condition due to severe postoperative complications, and when he was transferred to the authors' institution 43 days after birth, his respiratory condition was still unstable because of lower cranial nerve palsy. Chemotherapy with carboplatin and etoposide resulted in moderate shrinkage of the tumor. Further chemotherapy led to improvement in the patient's general condition and weight gain, which allowed for a second attempt at resection. During this second surgery, which was performed when the child was 8 months of age, after 8 courses of chemotherapy, the tumor was completely resected with little bleeding. Histological findings from the second operation were consistent with mature teratoma. This case indicates that upfront chemotherapy may be effective for the initial management of such cases. Although the objective response to the treatment was modest, chemotherapy reduced the hemorrhagic nature of the tumor, facilitated improvement of the patient's general condition, and allowed for successful resection.
机译:先天性颅内未成熟畸胎瘤预后不良,尚未阐明化学疗法对这些肿瘤的有用性。作者报告了在首次切除尝试失败后,通过新辅助化疗和手术成功治疗了先天性颅内未成熟畸胎瘤的病例。该患者为婴儿,他在12天时开始频繁呕吐,并在18天时因持续呕吐,头围增加和意识障碍而入院。大脑的CT扫描显示他的后颅窝和脑积水很大。手术是在紧急情况下进行的,但由于术中大量出血,只能进行较小的肿瘤切除。组织病理学诊断为未成熟畸胎瘤。婴儿由于严重的术后并发症而处于术后危急状态,出生后43天被转移到提交人所在的机构时,由于下颅神经麻痹,其呼吸情况仍然不稳定。卡铂和依托泊苷的化学疗法可导致肿瘤适度缩小。进一步的化疗导致患者的总体状况和体重增加的改善,从而允许再次尝试切除。在儿童8个月大时进行的第二次手术中,经过8个疗程的化疗,肿瘤完全切除,几乎没有出血。第二次手术的组织学结果与成熟的畸胎瘤一致。该病例表明前期化疗可能对此类病例的初始治疗有效。尽管对治疗的客观反应不大,但化学疗法可减少肿瘤的出血性质,有助于改善患者的总体状况,并可以成功切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号